客户发表文献

论文在线提交

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

开始时间
页码: 27/250 每页显示数量
ZIC5 promotes human hepatocellular carcinoma cell proliferation through upregulating COL1A1
Authors: Wenping Song, Weijiang Yu, Ding Li, Cheng Cheng, Xuan Wu, Jinhua Chen, Wenzhou Zhang
Journal: J Gastrointest Oncol
PubMed ID: 35837163
Doi: 10.21037/jgo-22-335
Mapping immunogenic epitopes of an adhesin-like protein from Methanobrevibacter ruminantium M1 and comparison of empirical data with in silico prediction methods
Authors: Sofia Khanum, Vincenzo Carbone, Sandeep K Gupta, Juliana Yeung, Dairu Shu, Tania Wilson, Natalie A Parlane, Eric Altermann, Silvia M Estein, Peter H Janssen, D Neil Wedlock, Axel Heiser
Journal: Sci Rep
PubMed ID: 35729277
Doi: 10.1038/s41598-022-14545-8
Persistence of immune responses to the Sinopharm/BBIBP-CorV vaccine
Authors: Chandima Jeewandara, Inoka Sepali Aberathna, Pradeep Darshana Pushpakumara, Achala Kamaladasa, Dinuka Guruge, Ayesha Wijesinghe, Banuri Gunasekera, Shyrar Tanussiya Ramu, Heshan Kuruppu, Thushali Ranasinghe, Shashika Dayarathna, Osanda Dissanayake, Nayanathara Gamalath, Dinithi Ekanayake, Jeewantha Jayamali, Deshni Jayathilaka, Madushika Dissanayake, Tibutius Thanesh Jayadas, Anushika Mudunkotuwa, Gayasha Somathilake, Michael Harvie, Thashmi Nimasha, Saubhagya Danasekara, Ruwan Wijayamuni, Lisa Schimanski, Pramila Rijal, Tiong K Tan, Tao Dong, Alain Townsend, Graham S Ogg, Gathsaurie Neelika Malavige
Journal: Immun Inflamm Dis
PubMed ID: 35634958
Doi: 10.1002/iid3.621
The PRMT5-LSD1 axis confers Slug dual transcriptional activities and promotes breast cancer progression
Authors: Jianchao Zhang, Xiaokai Fan, Yunfan Zhou, Liang Chen, Hai Rao
Journal: J Exp Clin Cancer Res
PubMed ID: 35655230
Doi: 10.1186/s13046-022-02400-7
Plasminogen and plasmin can bind to human T cells and generate truncated CCL21 that increases dendritic cell chemotactic responses
Authors: Evert J Loef, Hilary M Sheppard, Nigel P Birch, P Rod Dunbar
Journal: J Biol Chem
PubMed ID: 35690148
Doi: 10.1016/j.jbc.2022.102112
Aberrant DNA hydroxymethylation reshapes transcription factor binding in myeloid neoplasms
Authors: Jia Li, Tingting Hong, Yue Wei, Lei Guo, Minjung Lee, Hui Yang, Caleb Class, Yaling Yang, Xiaoqiong Wang, Hua He, Stefan Siwko, M James You, Yubin Zhou, Guillermo Garcia-Manero, Yun Huang
Journal: Clin Epigenetics
PubMed ID: 35765052
Doi: 10.1186/s13148-022-01297-5
Metal cofactor stabilization by a partner protein is a widespread strategy employed for amidase activation
Authors: Julia E Page, Meredith A Skiba, Truc Do, Andrew C Kruse, Suzanne Walker
Journal: Proc Natl Acad Sci U S A
PubMed ID: 35733252
Doi: 10.1073/pnas.2201141119
Structure and Protein-Protein Interactions of Ice Nucleation Proteins Drive Their Activity
Authors: Susan Hartmann, Meilee Ling, Lasse S A Dreyer, Assaf Zipori, Kai Finster, Sarah Grawe, Lasse Z Jensen, Stella Borck, Naama Reicher, Taner Drace, Dennis Niedermeier, Nykola C Jones, Søren V Hoffmann, Heike Wex, Yinon Rudich, Thomas Boesen, Tina Šantl-Temkiv
Journal: Front Microbiol
PubMed ID: 35783412
Doi: 10.3389/fmicb.2022.872306
Identification of Chemical Probes Targeting MBD2
Authors: Diane Erdmann, Jean Contreras, Rémy A Le Meur, Bruno Vitorge, Vincent Saverat, Ambre Tafit, Corinne Jallet, Véronique Cadet-Daniel, Corentin Bon, Phannarath Phansavath, Virginie Ratovelomanana-Vidal, Albert Jeltsch, Sophie Vichier-Guerre, J Iñaki Guijarro, Paola B Arimondo
Journal: ACS Chem Biol
PubMed ID: 35649238
Doi: 10.1021/acschembio.1c00959
Antibody-based redirection of universal Fabrack-CAR T cells selectively kill antigen bearing tumor cells
Authors: Yi-Chiu Kuo, Cheng-Fu Kuo, Kurt Jenkins, Alfur Fu-Hsin Hung, Wen-Chung Chang, Miso Park, Brenda Aguilar, Renate Starr, Jonathan Hibbard, Christine Brown, John C Williams
Journal: J Immunother Cancer
PubMed ID: 35728874
Doi: 10.1136/jitc-2021-003752
< 22 23 24 25 26 27 28 29 30 31 32 > Total Pages 250

喜欢新升级的网站吗?

讨厌

不喜欢

一般

喜欢

非常喜欢

*